Innovative solutions

Disruptive strategy to elicit protective immunity against Multidrug-resistant (MDR) Gram-negative bacteria

RemAb is developing a pipeline with different indications. Our most advanced program aims to provide immediate protection to patients admitted to Intensive Care Units (ICU) without generating antimicrobial resistance (AMR).
 

Read more

 

 

 

 

 

 

 

 

 

 

 

ABOUT US

RemAb Therapeutics is a spin‐off of Bellvitge Biomedical Research Institute, based in Barcelona.

 

PROBLEM

Antimicrobial resistance (AMR) is a growing global threat to human health and economic development.

 

.

 

PRODUCT

RA01 is novel drug product and a first line therapy for preventing nosocomial infections at ICUs.

 

 

.

 

 

Grants and Awards

 

  • Know more

    Grant from

    Fundació "La Caixa"

    Obra Social "La Caixa"

    CaixaImpulse program

    July / 2016

    Ref.: CI16-00037

    Read more

  • Know more

    Grant from

    CERCA

    Generalitat de Catalunya

    Fons de Patents Gínjol Program

    GAS-1: 2017 – 3rd edition

    GAS: 2016 - 1st edition 

    Read more

  • Know more

    Grant from

    EIT Health

    European Commission

    HeadStart Program

    July / 2018

    Ref. 2018-HS-0010

    Read more

  • Know more

    Grant from

    SME phase-I

    European Commission

    Horizon 2020

    December/ 2018

    Ref.: Coming soon

    Read more

  • Know more

    Grant from

    Startup Capital

    Generalitat de Catalunya

    ACCIO

    February/ 2019

    Ref.: Coming soon

    Read more

  • Know more

    Grant from

    Kingdom of Saudi Arabia

    Ministry of Education

    Integration in International programs of entrepreneurship

    February/ 2020

    Ref.:  Coming soon

    Read more

  • Know more

    Grant from

    Fundació "La Caixa"

    Obra Social "La Caixa"

    CaixaImpulseConsolidate program

    March/ 2020

    Ref.: Coming soon

    Read more

  • Know more

    Grant from

    BIOCAT

    Generalitat de Catalunya

    Emergency call against COVID-19

    April/ 2020

    Ref.:  Coming soon

    Read more

  • Know more

    Grant from

    CDTI

    Ministerio de Ciencia e Innovación

    Neotec Program

    December/ 2020

    Ref.:  Coming soon

    Read more